For instance, lung cancer cells expressing high levels of HO-1 were less sensitive to cisplatin, and the genetic or pharmacologic inhibition of HO-1 activity by siRNA or zinc protoporphyrin IX (ZnPP), respectively augmented the cytotoxic effect of this anticancer drug. The gene discussed is HMOX1; the disease is lung carcinoma.